Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Protocol to Decrease Peri-procedural and Intra-operative Hemorrhage in Children With Alagille Syndrome

NCT05846854 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05846854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05846854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Protocol to Decrease Peri-procedural and Intra-operative Hemorrhage in Children With Alagille Syndrome
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Unknown status
Start date
April 18, 2023
Completion date
November 30, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired von willebrand disease, alagille syndrome, pulmonary artery stenoses